AXLA insider filings
Axcella Health Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-03. Screen AXLA transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AXLA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Axcella Health Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-03-03 | 4 | Koziel Margaret — Chief Medical Officer | Sale (S): 679 @ $0.58 | EDGAR |
| 2023-02-24 | 4 | Koziel Margaret — Chief Medical Officer | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2023-02-24 | 4 | Hinshaw William — President & CEO, Director | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2023-02-24 | 4 | Fehlner Paul — SVP & Chief Legal Officer | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2023-02-13 | 4 | Fehlner Paul — SVP & Chief Legal Officer | Sale (S): 5,221 @ $0.66 | EDGAR |
| 2022-11-18 | 4 | NISSEN TORBEN STRAIGHT — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-11-18 | 4 | Rosiello Robert L. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-10-19 | 4 | Hinshaw William — President & CEO, Director | Grant/award (A): 50,000 · Sale (S): 16,000 @ $1.56 | EDGAR |
| 2022-10-17 | 4 | Societe des Produits Nestle S.A. — 10% owner NESTLE SA — 10% owner | Purchase (P): 3,658,536 @ $1.64 | EDGAR |
| 2022-10-17 | 4 | Flagship Ventures Fund IV General Partner LLC — 10% owner Flagship Ventures Fund IV, L.P. — 10% owner Flagship Ventures Opportunities Fund I General Partner LLC — 10% owner Flagship Ventures Opportunities Fund I, L.P. — 10% owner AFEYAN NOUBAR — 10% owner | Purchase (P): 2,743,902 @ $1.64 · Purchase (P): 2,757,333 @ $1.64 · Purchase (P): 914,634 @ $1.64 · Purchase (P): 919,111 @ $1.64 · Purchase (P): 3,048,780 @ $1.64 | EDGAR |
| 2022-09-08 | 4 | Koziel Margaret — Chief Medical Officer | Sale (S): 547 @ $2.52 | EDGAR |
| 2022-06-03 | 4 | Epstein David R — Director | Grant/award (A): 47,059 @ $0 | EDGAR |
| 2022-06-02 | 4 | Koziel Margaret — Chief Medical Officer | Sale (S): 590 @ $2.01 | EDGAR |
| 2022-05-25 | 4 | SEKHRI PAUL J — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-05-23 | 4 | Hendrix Martin — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-05-23 | 4 | Rondinone CRISTINA — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-05-23 | 4 | Pisano Gary P. — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-05-23 | 4 | Sohn Catherine A. — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-05-23 | 4 | Baird William D III — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-05-23 | 4 | Rosenblatt Michael — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-03-21 | 4 | Epstein David R — Director | Option exercise (M): 1,535 · Grant/award (A): 50,000 (derivative) @ $0 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2022-03-18 | 4 | Hinshaw William — President & CEO, Director | Purchase (P): 13,089 @ $1.91 | EDGAR |
| 2022-03-18 | 4 | Fehlner Paul — SVP & Chief Legal Officer | Purchase (P): 10,471 @ $1.91 | EDGAR |
| 2022-03-18 | 4 | Epstein David R — Director | Purchase (P): 26,178 @ $1.91 | EDGAR |
| 2022-03-18 | 4 | Crane Robert — Chief Financial Officer | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2022-03-18 | 4 | Crane Robert — Chief Financial Officer | Purchase (P): 39,267 @ $1.91 | EDGAR |
| 2022-03-18 | 4 | Flagship Ventures Fund IV General Partner LLC — 10% owner Flagship Ventures Fund IV, L.P. — 10% owner Flagship Ventures Fund IV-Rx, L.P. — 10% owner Flagship Ventures Opportunities Fund I General Partner LLC — 10% owner Flagship Ventures Opportunities Fund I, L.P. — 10% owner AFEYAN NOUBAR — 10% owner | Purchase (P): 3,791,623 @ $1.91 · Purchase (P): 947,905 @ $1.91 · Purchase (P): 1,579,843 @ $1.91 | EDGAR |
| 2022-03-16 | 4 | Societe des Produits Nestle S.A. — 10% owner NESTLE SA — 10% owner | Purchase (P): 3,141,361 @ $1.91 | EDGAR |
| 2022-03-03 | 4 | Koziel Margaret — Chief Medical Officer | Sale (S): 553 @ $1.86 | EDGAR |
| 2022-02-23 | 4 | Epstein David R — Director | Option exercise (M): 1,534 · Option exercise (M): 1,534 (derivative) @ $0 | EDGAR |
| 2022-02-10 | 4 | Schecter Alison D. — President - Research & Dev. | Grant/award (A): 56,000 (derivative) @ $0 | EDGAR |
| 2022-02-10 | 4 | Fehlner Paul — SVP & Chief Legal Officer | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2022-02-10 | 4 | Hinshaw William — President & CEO, Director | Grant/award (A): 275,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-02-10 | 4 | Koziel Margaret — Chief Medical Officer | Grant/award (A): 33,397 (derivative) @ $0 | EDGAR |
| 2022-02-10 | 4 | Dean Virginia R — SVP, Chief People Officer | Grant/award (A): 71,400 (derivative) @ $0 | EDGAR |
| 2022-02-01 | 4 | Hinshaw William — President and CEO, Director | Option exercise (M): 50,000 · Sale (S): 16,590 @ $1.65 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | Epstein David R — Director | Option exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2021-12-20 | 4 | Epstein David R — Director | Option exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Schecter Alison D. — President - Research & Dev. | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-12-13 | 4 | Koziel Margaret — Chief Medical Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2021-11-22 | 4 | Epstein David R — Director | Option exercise (M): 1,534 · Option exercise (M): 1,534 (derivative) @ $0 | EDGAR |
| 2021-10-19 | 4 | Epstein David R — Director | Option exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2021-09-20 | 4 | Epstein David R — Director | Option exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2021-08-25 | 4 | Pisano Gary P. — Director | Option exercise (M): 81,433 @ $0.28 · Option exercise (M): 81,433 (derivative) @ $0 | EDGAR |
| 2021-08-19 | 4 | Epstein David R — Director | Option exercise (M): 1,534 · Option exercise (M): 1,534 (derivative) @ $0 | EDGAR |
| 2021-07-20 | 4 | Epstein David R — Director | Option exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | Dean Virginia R — SVP, Chief People Officer | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Epstein David R — Director | Option exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2021-05-24 | 4 | Sohn Catherine A. — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-05-24 | 4 | Baird William D III — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Axcella Health Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-12-22 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2023-12-19 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets | EDGAR |
| 2023-12-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-11-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-11-09 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-11-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-06 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events | EDGAR |
| 2023-09-18 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AXLA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs